These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 6373343)

  • 21. Effect of almitrine bismesylate on the distribution of ventilation and mechanics of breathing in patients with COLD.
    Yernault JC; Van Muylem A; Noseda A; Ravez P; Paiva M
    Eur J Respir Dis Suppl; 1983; 126():265-70. PubMed ID: 6373341
    [No Abstract]   [Full Text] [Related]  

  • 22. [Treatment of hematosis disorders in chronic obstructive bronchitis with almitrine bismesylate].
    González Montaner LJ
    Medicina (B Aires); 1986; 46(6):739-41. PubMed ID: 3306258
    [No Abstract]   [Full Text] [Related]  

  • 23. [Almitrine bismesylate in chronic obstructive lung disease and persistent hypoxemia. Controlled double-blind study with oral administration].
    Wuttke R; von Wichert P
    Respiration; 1985; 48(4):285-95. PubMed ID: 3936140
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Almitrine has no effect on gas exchange after bilateral carotid body resection in severe chronic airflow obstruction.
    De Backer W; Vermeire P; Bogaert E; Janssens E; Van Maele R
    Bull Eur Physiopathol Respir; 1985; 21(5):427-32. PubMed ID: 3904873
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Dyspnea in chronic bronchitis patients. A method for diagnosis and monitoring therapeutic efficacy].
    Tellier P
    Presse Med; 1984 Oct; 13(34):2049-53. PubMed ID: 6149531
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of almitrine bismesylate on arterial blood gases and ventilatory drive in patients with severe chronic airflow obstruction and bilateral carotid body resection.
    de Backer W; Bogaert E; Van Maele R; Vermeire P
    Eur J Respir Dis Suppl; 1983; 126():239-42. PubMed ID: 6426993
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A one-year double-blind placebo-controlled study of the efficacy and safety of almitrine bismesylate in hypoxic COLD patients. Monitoring progress status on 490 patients entered into the VIMS study before January 1st, 1984.
    Ansquer JC
    Eur J Respir Dis Suppl; 1986; 146():703-12. PubMed ID: 3536563
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Vectarian international multicenter study (VIMS) in hypoxemic chronic bronchitis patients treated by the double-blind placebo method for 1 year. Follow-up of the monitoring of 490 patients].
    Ansquer JC
    Rev Med Interne; 1985; 6 Spec No():31-7. PubMed ID: 3914682
    [No Abstract]   [Full Text] [Related]  

  • 29. [Almitrine bismesylate].
    Duroux P
    Rev Mal Respir; 1985; 2 Suppl 1():S1-2. PubMed ID: 2870541
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of almitrine on the regional distribution of ventilation and perfusion in chronic bronchitis.
    Nunn PP; Myers MJ; Wang YT; Lavender JP; Hughes JM
    Bull Eur Physiopathol Respir; 1984; 20(1):37-42. PubMed ID: 6704563
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Almitrine dimesylate: deductions and therapeutic prospects].
    Tellier P; Voisin C
    Presse Med; 1984 Oct; 13(34):2099-103. PubMed ID: 6149539
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of almitrine bismesylate in acute respiratory failure.
    Lambropoulos S; Chatzipappas A; Tsekos G; Tsantoulis K
    Eur J Respir Dis Suppl; 1986; 146():657-61. PubMed ID: 3465586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of almitrine bismesylate on nocturnal hypoxemia in patients with chronic bronchitis and obesity.
    Marrone O; Milone F; Coppola P; Oddo S; Giannone G; Macaluso C; Bonsignore G
    Eur J Respir Dis Suppl; 1986; 146():641-8. PubMed ID: 3096764
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term oral acetylcysteine in chronic bronchitis. a double-blind controlled study.
    Eur J Respir Dis Suppl; 1980; 111():93-108. PubMed ID: 7011836
    [No Abstract]   [Full Text] [Related]  

  • 35. [Treatment of chronic obstructive bronchitis with almitrine].
    Pilheu JA
    Medicina (B Aires); 1987; 47(4):442. PubMed ID: 2898724
    [No Abstract]   [Full Text] [Related]  

  • 36. [Almitrine dimesylate (vectarion)--the first representative of a new group of "synergetic" drugs--and its use in pulmonary pathology].
    Mihalţan F
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1987; 36(3):209-19. PubMed ID: 2894713
    [No Abstract]   [Full Text] [Related]  

  • 37. [Originality of the mode of action of almitrine dimesylate].
    Tellier P
    Presse Med; 1984 Oct; 13(34):2083-9. PubMed ID: 6149536
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment of hematosis disorders in chronic obstructive bronchitis with almitrine bismesilate].
    Raimondi GA
    Medicina (B Aires); 1987; 47(6):687-8. PubMed ID: 3504999
    [No Abstract]   [Full Text] [Related]  

  • 39. The effect of almitrine bismesylate on hypoxemia in chronic obstructive pulmonary disease.
    Bell RC; Mullins RC; West LG; Bachand RT; Johanson WG
    Ann Intern Med; 1986 Sep; 105(3):342-6. PubMed ID: 3527011
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical investigation of a new broncholyticum--decloxizine--as compared with franol and placebo treatment.
    Kiehelä J; Keskinen H; Hohenthal TT
    Respiration; 1970; 27(6):582-90. PubMed ID: 4395228
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.